文献

J-GLOBAL ID：201802221142810591   整理番号：18A0118693

遺伝子型1b慢性C型肝炎を有する透析患者におけるオムビタスビル/パリタプレビル/リトナビルの有効性と安全性

Efficacy and safety of ombitasvir/paritaprevir/ritonavir in dialysis patients with genotype 1b chronic hepatitis C

著者 (19件)： Atsukawa Masanori (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan) ,  Atsukawa Masanori (Department of Internal Medicine, Division of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan) ,  Tsubota Akihito (Core Research Facilities for Basic Science, Jikei University School of Medicine, Tokyo, Japan) ,  Koushima Yohei (Division of Gastroenterology and Hepatology, Japanese Red Cross Saitama Hospital, Saitama, Japan) ,  Ikegami Tadashi (Department of Internal Medicine, Division of Hepatology and Gastroenterology, Tokyo Medical University, Ibaraki Medical Center, Ibaraki, Japan) ,  Watanabe Kouji (Department of Internal Medicine, Division of Gastroenterology, Mito Saiseikai General Hospital, Ibaraki, Japan) ,  Shimada Noritomo (Department of Internal Medicine, Division of Gastroenterology and Hepatology, Otakanomori Hospital, Chiba, Japan) ,  Sato Shinichi (Department of Internal Medicine, Division of Gastroenterology and Hepatology, Seirei Sakura Citizen Hospital, Chiba, Japan) ,  Kato Keizo (Department of Internal Medicine, Division of Gastroenterology and Hepatology, Shinmatsudo Central General Hospital, Chiba, Japan) ,  Abe Hiroshi (Department of Internal Medicine, Division of Gastroenterology and Hepatology, Shinmatsudo Central General Hospital, Chiba, Japan) ,  Okubo Tomomi (Department of Internal Medicine, Division of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan) ,  Arai Taeang (Department of Internal Medicine, Division of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan) ,  Itokawa Norio (Department of Internal Medicine, Division of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan) ,  Kondo Chisa (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan) ,  Mikami Shigeru (Department of Internal Medicine, Division of Gastroenterology, Kikkoman General Hospital, Chiba, Japan) ,  Asano Toru (Department of Internal Medicine, Division of Gastroenterology and Hepatology, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan) ,  Chuganji Yoshimichi (Department of Internal Medicine, Division of Gastroenterology and Hepatology, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan) ,  Matsuzaki Yasushi (Department of Internal Medicine, Division of Hepatology and Gastroenterology, Tokyo Medical University, Ibaraki Medical Center, Ibaraki, Japan) ,  Iwakiri Katsuhiko (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan)
資料名： Hepatology Research  (Hepatology Research)
巻： 47  号： 13  ページ： 1429-1437  発行年： 2017年12月 
JST資料番号： W1284A  ISSN： 1386-6346  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： オーストラリア (AUS)  言語： 英語 (EN)

抄録/ポイント： 目的:薬物動態の観点からは,日本の遺伝子型1b慢性C型肝炎の...

シソーラス用語： ヒト ,...
準シソーラス用語： 遺伝子型1b

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0118693&from=J-GLOBAL&jstjournalNo=W1284A") }}

著者キーワード (5件)： C型慢性肝炎 ,  透析 ,  末期腎疾患 ,  遺伝子型1b ,  ombitasvir/paritaprevir/リトナビル

分類 (1件)： 消化器疾患の薬物療法  (GH05020G)

物質索引 (3件)： オムビタスビル ,  パリタプレビル ,  リトナビル

引用文献 (47件)：

• Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 2014; 61: S45-S57.
• Di Bisceglie AM. Natural history of hepatitis C: its impact on clinical management. Hepatology 2000; 31: 1014-8.
• Fattovich G, Giustina G, Degos F et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 112: 463-72.
• Thomas DL, Seeff LB. Natural history of hepatitis C. Clin Liver Dis 2005; 9: 383-98.
• Simonetti RG, Cammà C, Fiorello F et aL Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med 1992; 116: 97-102.

タイトルに関連する用語 (8件)： 遺伝子型1b ,  慢性C型肝炎 ,  透析患者 ,  オムビタスビル ,  パリタプレビル ,  リトナビル ,  有効性 ,  安全性